Jazz Cools On Women’s Health, Sells Unit To Meda
This article was originally published in The Pink Sheet Daily
Executive Summary
The sale of an asset portfolio that includes Elsetrin for hot flashes could give Jazz the financial flexibility for another product acquisition.